表紙:高薬理活性APIの世界市場 (2021年) - COVID-19による成長と変化 (2030年まで)
市場調査レポート
商品コード
1028802

高薬理活性APIの世界市場 (2021年) - COVID-19による成長と変化 (2030年まで)

HP (High Potency) APIs Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.50円
高薬理活性APIの世界市場 (2021年) - COVID-19による成長と変化 (2030年まで)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の高薬理活性API市場について調査分析し、市場の特徴、市場規模と成長率、市場セグメンテーション、地域別・国別の内訳、競合情勢、市場シェア、動向と戦略について、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 高薬理活性API市場の特徴

第3章 高薬理活性API市場の動向と戦略

第4章 高薬理活性APIに対するCOVID-19の影響

第5章 高薬理活性APIの市場規模と成長率

  • 世界の高薬理活性API市場実績 (金額)
  • 世界の高薬理活性API市場予測 (金額)

第6章 高薬理活性API市場セグメンテーション

  • 世界の高薬理活性API市場:タイプ別、実績と予測 (金額)
  • 革新的
  • ジェネリック
  • 世界の高薬理活性API市場:合成タイプ別、実績と予測 (金額)
  • 合成
  • バイオテクノロジー
  • 高薬理活性API市場:治療適応別、実績と予測 (金額)
  • 腫瘍
  • ホルモン障害
  • 緑内障
  • その他

第7章 高薬理活性API市場の地域別・国別分析

  • 世界の高薬理活性API市場:地域別、実績と予測 (金額)
  • 世界の高薬理活性API市場:国別、実績と予測 (金額)

第8章 アジア太平洋地域の高薬理活性API市場

  • アジア太平洋地域の高薬理活性API市場概要
  • 地域情報、COVID-19の影響、市場情報、背景情報、政府のイニシアチブ、規制、規制機関、主要な協会、課税、法人税構造、投資、主要企業
  • アジア太平洋地域の高薬理活性API市場:タイプ別、実績と予測 (金額)

第9章 中国の高薬理活性API市場

  • 中国の高薬理活性API市場概要
  • 中国の高薬理活性API市場:タイプ別、実績と予測 (金額)

第10章 インドの高薬理活性API市場

  • インドの高薬理活性API市場:タイプ別、実績と予測 (金額)

第11章 日本の高薬理活性API市場

  • 日本の高薬理活性API市場:タイプ別、実績と予測 (金額)

第12章 オーストラリアの高薬理活性API市場

  • オーストラリアの高薬理活性API市場:タイプ別、実績と予測 (金額)

第13章 インドネシアの高薬理活性API市場

  • インドネシアの高薬理活性API市場:タイプ別、実績と予測 (金額)

第14章 韓国の高薬理活性API市場

  • 韓国の高薬理活性API市場:タイプ別、実績と予測 (金額)

第15章 西欧の高薬理活性API市場

  • 西欧の高薬理活性API市場概要
  • 西欧の高薬理活性API市場:タイプ別、実績と予測 (金額)

第16章 英国の高薬理活性API市場

  • 英国の高薬理活性API市場:タイプ別、実績と予測 (金額)

第17章 ドイツの高薬理活性API市場

  • ドイツの高薬理活性API市場:タイプ別、実績と予測 (金額)

第18章 フランスの高薬理活性API市場

  • フランスの高薬理活性API市場:タイプ別、実績と予測 (金額)

第19章 東欧の高薬理活性API市場

  • 東欧の高薬理活性API市場概要
  • 東欧の高薬理活性API市場:タイプ別、実績と予測 (金額)

第20章 ロシアの高薬理活性API市場

  • ロシアの高薬理活性API市場:タイプ別、実績と予測 (金額)

第21章 北米の高薬理活性API市場

  • 北米の高薬理活性API市場概要
  • 北米の高薬理活性API市場:タイプ別、実績と予測 (金額)

第22章 米国の高薬理活性API市場

  • 米国の高薬理活性API市場概要
  • 米国の高薬理活性API市場:タイプ別、実績と予測 (金額)

第23章 南米の高薬理活性API市場

  • 南米の高薬理活性API市場概要
  • 南米の高薬理活性API市場:タイプ別、実績と予測 (金額)

第24章 ブラジルの高薬理活性API市場

  • ブラジルの高薬理活性API市場:タイプ別、実績と予測 (金額)

第25章 中東の高薬理活性API市場

  • 中東の高薬理活性API市場概要
  • 中東の高薬理活性API市場:タイプ別、実績と予測 (金額)

第26章 アフリカの高薬理活性API市場

  • アフリカの高薬理活性API市場概要
  • アフリカの高薬理活性API市場:タイプ別、実績と予測 (金額)

第27章 高薬理活性API市場の競合情勢と企業プロファイル

  • 高薬理活性API市場の競合情勢
  • 高薬理活性API市場の企業プロファイル
    • Eli Lily and Company
    • Novartis AG
    • Bristol-Myers Squibb Company
    • Roche Diagnostics Ltd.
    • Sanofi

第28章 高薬理活性APIのパイプライン分析

第29章 高薬理活性API市場における主要なM&A

第30章 高薬理活性API市場の将来見通しと潜在的分析

第31章 付録

目次
Product Code: h826

“HP (High Potency) APIs Global Market Report 2021: COVID-19 Growth And Change to 2030” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global high potency APIs.

This report focuses on the high potency APIs market which is experiencing strong growth. The report gives a guide to the high potency APIs market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the high potency APIs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The High Potency APIs market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider high potency APIs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The high potency APIs market section of the report gives context. It compares the high potency APIs market with other segments of the high potency APIs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, high potency APIs indicators comparison.

Scope

Markets Covered:

1) By Type: Innovative HPAPI; Generic HPAPI

2) By Synthesis Type: Synthetic HPAPI; Biotech HPAPI

3) By Therapeutic Application: Oncology; Harmonal Disorder; Glaucoma; Other Therapeutic Applications (Respiratory Disorders, CVD, Diabetes, Cosmetology, and Erectile Dysfunction)

Companies Mentioned: Eli Lily and Company; Novartis AG; Bristol-Myers Squibb Company; Roche Diagnostics Ltd.; Sanofi

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. HP (High Potency) APIs Market Characteristics

3. HP (High Potency) APIs Market Trends And Strategies

4. Impact Of COVID-19 On HP (High Potency) APIs

5. HP (High Potency) APIs Market Size And Growth

  • 5.1. Global HP (High Potency) APIs Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global HP (High Potency) APIs Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. HP (High Potency) APIs Market Segmentation

  • 6.1. Global HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Innovative HPAPI
  • Generic HPAPI
  • 6.2. Global HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Synthetic HPAPI
  • Biotech HPAPI
  • 6.3. Global HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oncology
  • Harmonal Disorder
  • Glaucoma
  • Other Therapeutic Applications (Respiratory Disorders, CVD, Diabetes, Cosmetology, and Erectile Dysfunction)

7. HP (High Potency) APIs Market Regional And Country Analysis

  • 7.1. Global HP (High Potency) APIs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global HP (High Potency) APIs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific HP (High Potency) APIs Market

  • 8.1. Asia-Pacific HP (High Potency) APIs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China HP (High Potency) APIs Market

  • 9.1. China HP (High Potency) APIs Market Overview
  • 9.2. China HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India HP (High Potency) APIs Market

  • 10.1. India HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan HP (High Potency) APIs Market

  • 11.1. Japan HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia HP (High Potency) APIs Market

  • 12.1. Australia HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia HP (High Potency) APIs Market

  • 13.1. Indonesia HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea HP (High Potency) APIs Market

  • 14.1. South Korea HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe HP (High Potency) APIs Market

  • 15.1. Western Europe HP (High Potency) APIs Market Overview
  • 15.2. Western Europe HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK HP (High Potency) APIs Market

  • 16.1. UK HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany HP (High Potency) APIs Market

  • 17.1. Germany HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France HP (High Potency) APIs Market

  • 18.3. France HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe HP (High Potency) APIs Market

  • 19.1. Eastern Europe HP (High Potency) APIs Market Overview
  • 19.2. Eastern Europe HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia HP (High Potency) APIs Market

  • 20.1. Russia HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America HP (High Potency) APIs Market

  • 21.1. North America HP (High Potency) APIs Market Overview
  • 21.2. North America HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA HP (High Potency) APIs Market

  • 22.1. USA HP (High Potency) APIs Market Overview
  • 22.2. USA HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America HP (High Potency) APIs Market

  • 23.1. South America HP (High Potency) APIs Market Overview
  • 23.2. South America HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil HP (High Potency) APIs Market

  • 24.1. Brazil HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East HP (High Potency) APIs Market

  • 25.1. Middle East HP (High Potency) APIs Market Overview
  • 25.2. Middle East HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa HP (High Potency) APIs Market

  • 26.1. Africa HP (High Potency) APIs Market Overview
  • 26.2. Africa HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. HP (High Potency) APIs Market Competitive Landscape And Company Profiles

  • 27.1. HP (High Potency) APIs Market Competitive Landscape
  • 27.2. HP (High Potency) APIs Market Company Profiles
    • 27.2.1. Eli Lily and Company
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Novartis AG
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Bristol-Myers Squibb Company
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Roche Diagnostics Ltd.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Sanofi
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. HP (High Potency) APIs Pipeline Analysis

29. Key Mergers And Acquisitions In The HP (High Potency) APIs Market

30. HP (High Potency) APIs Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer